Association between tumor burden and response to immunotherapy in patients with metastatic renal cell carcinoma.

被引：0
|
作者：
Yasin, Hesham Abdallah
Chen, Yu-Wei
Tucker, Matthew D.
Beckermann, Katy
Schaffer, Kerry
Davis, Nancy B.
McAlister, Renee
Wallace, Deborah
Kaiser, Elizabeth
Rini, Brian I.
机构：
[1] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4541
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The components of tumor microenvironment as biomarker for immunotherapy in metastatic renal cell carcinoma
    Su, Jiaming
    Zhou, Lu
    Zhang, Zhe
    Xiao, Xue
    Qin, Yanning
    Zhou, Xiaoying
    Huang, Tingting
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [32] Primary Tumor Response to Targeted Agents in Patients with Metastatic Renal Cell Carcinoma
    Abel, E. Jason
    Culp, Stephen H.
    Tannir, Nizar M.
    Matin, Surena F.
    Tamboli, Pheroze
    Jonasch, Eric
    Wood, Christopher G.
    EUROPEAN UROLOGY, 2011, 59 (01) : 10 - 15
  • [33] Association between clonal hematopoiesis and survival after nephrectomy in patients with renal cell carcinoma.
    Khandwala, Yash
    Ruthen, Neil
    Kotecha, Ritesh R.
    Russo, Paul
    Coleman, Jonathan
    Reznik, Eduard
    Hakimi, A. Ari
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [34] Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy
    Iris Y. Sheng
    Shilpa Gupta
    Chandana A. Reddy
    Dana Angelini
    Pauline Funchain
    Tamara A. Sussman
    Joseph Sleiman
    Moshe C. Ornstein
    Keith McCrae
    Alok A. Khorana
    Targeted Oncology, 2021, 16 : 813 - 821
  • [35] Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy
    Sheng, Iris Y.
    Gupta, Shilpa
    Reddy, Chandana A.
    Angelini, Dana
    Funchain, Pauline
    Sussman, Tamara A.
    Sleiman, Joseph
    Ornstein, Moshe C.
    McCrae, Keith
    Khorana, Alok A.
    TARGETED ONCOLOGY, 2021, 16 (06) : 813 - 821
  • [36] Venous tumor thrombus destinations in patients with renal cell carcinoma.
    Nabavizadeh, Reza
    Pessoa, Rodrigo
    Cheville, John
    Lohse, Christine M.
    Costello, Brian Addis
    Lucien, Fabrice
    Thompson, Houston R.
    Boorjian, Stephen A.
    Leibovich, Bradley C.
    Sharma, Vidit
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 381 - 381
  • [37] Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma
    Chehrazi-Raffle, Alexander
    Muddasani, Ramya
    Dizman, Nazli
    Hsu, Joann
    Meza, Luis
    Zengin, Zeynep B.
    Malhotra, Jasnoor
    Chawla, Neal
    Dorff, Tanya
    Contente-Cuomo, Tania
    Dinwiddie, Devin
    McDonald, Bradon R.
    McDaniel, Timothy
    Trent, Jeffrey M.
    Baehner, Frederick L.
    Murtaza, Muhammed
    Pal, Sumanta K.
    JCO PRECISION ONCOLOGY, 2023, 7
  • [38] Interferon-α-based Immunotherapy in Metastatic Renal Cell Carcinoma Patients with the Primary Tumor In Situ
    Shinohara, Nobuo
    Abe, Takashige
    Sazawa, Ataru
    Maruyama, Satoru
    Shindo, Junri
    Sato, Soshu
    Suzuki, Shin
    Nonomura, Katsuya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (02) : 113 - 119
  • [39] Intradermal RNA-vaccination of patients with metastatic renal cell carcinoma.
    Wierecky, J
    Müller, MR
    Häntschel, M
    Horger, MS
    Pascolo, S
    Brugger, W
    Kanz, L
    Brossart, P
    BLOOD, 2005, 106 (11) : 51B - 51B
  • [40] Impact of statins and survival outcomes in patients with metastatic renal cell carcinoma.
    McKay, Rana R.
    Lin, Xun
    Albiges, Laurence K.
    Fay, Andre Poisl
    Kaymakcalan, Marina Dusevic
    Mickey, Suzanne S.
    Ghoroghchian, Paiman Peter
    Bhatt, Rupal Satish
    Simantov, Ronit
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345